J&J | Lånekapital



Loan Capital Endring Dato
AbbVie USD 60.34B 1.83B 2024-12
Abbott USD 12.74B 111M 2025-03
Amgen USD 56.55B 305M 2024-12
AstraZeneca USD 27.89B 154M 2025-03
Baxter International USD 10.37B 63M 2024-12
Bayer EUR 34.55B 2.12B 2024-12
Becton, Dickinson and Co. USD 17.44B 500M 2024-12
Biogen USD 4.55B 1.4M 2024-12
Boston Scientific USD 8.97B 265M 2024-12
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
CONMED USD 905.07M 35.03M 2024-12
Cooper Companies USD 2.49B 59.2M 2025-01
Dexcom USD 1.3B 1.2B 2024-12
Edwards Lifesciences USD 597.7M 200K 2024-12
Eli Lilly USD 34.5B 5.97B 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
Globus Medical USD 298K 411K 2024-12
Hologic USD 2.49B 19M 2024-12
Indivior 311M 4M 2025-03
Insulet USD 1.3B 60.2M 2024-12
Integra LifeSciences USD 1.2B 9.07M 2024-12
Intuitive Surgical USD 0 0 2025-03
J&J USD 38.36B 7.7B 2025-03
Medtronic USD 23.99B 622M 2025-01
Merck USD 34.46B 520M 2024-12
Merit Medical Systems USD 730.67M 1.12M 2025-03
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.4B 597M 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.41B 1.62B 2025-03
Stryker USD 12.19B 1.14B 2024-12
Tandem Diabetes Care USD 313.6M 5.34M 2025-03
Teva Pharmaceutical Industries USD 16B 398M 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zimmer Biomet Holdings USD 5.34B 603.9M 2024-12
Zoetis USD 5.22B 1.35B 2024-12



J&J Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.